Two experimental drug molecules promoted myelin repair in MS disease models, pointing toward a possible future route for ...

As recently as the ‘90s, when patients arrived with all the typical symptoms — memory loss, double vision, fatigue — neurologists often avoided confirming what they most suspected: that the patient ...

TREATMENT HAS ALREADY CHANGED MILLIONS OF LIVES IN THIS BUILDING. ONE DOCTOR DISCOVERED A BREAKTHROUGH THAT IS CHANGING THE LIVES OF PEOPLE LIVING WITH MULTIPLE SCLEROSIS. THESE PATIENTS, WITH ...

Should multiple sclerosis (MS) patients stop disease-modifying treatment (DMT) as they get older? The answer depends on several factors, noted John Corboy, MD, of the Rocky Mountain MS Center at the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. March is Multiple Sclerosis Awareness Month, a time to ...

Hundreds of patients of multiple sclerosis (MS) in Punjab are facing uncertainty regarding continued funding for access to treatment available under the provincial healthcare system.Neurologists ...

If you’ve been recently diagnosed with SPMS, you may wonder how the transition between RRMS and SPMS will affect your MS treatment options and lifestyle. Most people with MS are initially diagnosed ...

Staying on top of multiple sclerosis can be challenging. Here's how to optimize your treatment and quality of life.

Cantex and Headlamp Health are teaming up to accelerate the development of azeliragon for severe depression and fatigue in MS ...

A new study compares CPZ and LPC models, creating a genetic roadmap to accelerate myelin regeneration therapies for Multiple ...

A novel program provided evidence that addressing long-known disparities in high-efficacy multiple sclerosis (MS) treatment for minority populations is a solvable problem. The program, presented by ...